Order Article Reprints

Mohapatra S, Guerrero A, Rahman N, Zaman KT, Wu J, Onyeagba C, Hu C, Pellegrini M, Vankudoth J, Kitamura S, et al. Novel Taxol-Derivative, STO-1, Induces Selective Anti-Tumor Immunity and Sustained Remission of Glioblastoma Without Triggering Autoimmune Reactions. Cells. 2025; 14(21):1703. https://doi.org/10.3390/cells14211703

Mohapatra, Shubhasmita, Adrian Guerrero, Neha Rahman, Khondoker Takia Zaman, Jing Wu, Callistus Onyeagba, Chanyue Hu, Matteo Pellegrini, Jayaram Vankudoth, Seiya Kitamura, and et al. 2025. "Novel Taxol-Derivative, STO-1, Induces Selective Anti-Tumor Immunity and Sustained Remission of Glioblastoma Without Triggering Autoimmune Reactions" Cells 14, no. 21: 1703. https://doi.org/10.3390/cells14211703

Mohapatra, S., Guerrero, A., Rahman, N., Zaman, K. T., Wu, J., Onyeagba, C., Hu, C., Pellegrini, M., Vankudoth, J., Kitamura, S., O’Donnell, L., Wadghiri, Y. Z., & Banerjee, P. (2025). Novel Taxol-Derivative, STO-1, Induces Selective Anti-Tumor Immunity and Sustained Remission of Glioblastoma Without Triggering Autoimmune Reactions. Cells, 14(21), 1703. https://doi.org/10.3390/cells14211703